Ali-Jackson Kamil insider trades
Ali-Jackson Kamil has filed 15 Form 4s with the SEC that we hold, for Rigel Pharmaceuticals INC (RIGL) (Director), PDS Biotechnology Corp (PDSB) (Director) and Aclaris Therapeutics, Inc. (ACRS) (Chief Legal Officer). Across all of them we count 0 purchases worth $0 and 2 sales worth $160.4K reported on Form 4. In the last 12 months: 0 purchases ($0) and 2 sales ($160.4K). The largest single trade was a sale of 2,500 shares of Rigel Pharmaceuticals INC worth $87.5K, dated 2026-06-22. The first filing on our record is dated 2021-11-22 and the latest 2026-06-24.
Rigel Pharmaceuticals INC (RIGL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-05-26 | S, sale reported on Form 4 | 2,500 | $72.9K | 2026-05-28 |
| 2026-06-22 | S, sale reported on Form 4 | 2,500 | $87.5K | 2026-06-24 |
PDS Biotechnology Corp (PDSB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Aclaris Therapeutics, Inc. (ACRS)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1654337) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms